Mark Stein clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer…Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)

   Trial completed

   Also in this update: Study completion date changed from estimate of Jan 2026 to May 2, 2024

   Mark Stein·Phase 1/2· NCT03689699· Registry history of NCT03689699 on ClinicalTrials.gov (opens the registry)

   Oct 15, 2026

2. Minor

   ADXS-504 Immunotherapy for Recurrent Prostate Cancer

   Trial completed

   Also in this update: Primary completion date changed from estimate of Jul 2026 to Apr 10, 2025

   Mark Stein·Phase 1· NCT05077098· Registry history of NCT05077098 on ClinicalTrials.gov (opens the registry)

   Sep 25, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.